-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HwdHf/cZr+JH8ZzF7W0EjVTJsgzLzkwowb2wSQf5mzqatDFtnFhYuVp2Xz6ohKrX /DX3xfVcTEa6Kj3X51CYow== 0001104659-08-009496.txt : 20080212 0001104659-08-009496.hdr.sgml : 20080212 20080212183028 ACCESSION NUMBER: 0001104659-08-009496 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080208 FILED AS OF DATE: 20080212 DATE AS OF CHANGE: 20080212 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVI BIOPHARMA INC CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: OR FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE SW COLUMBIA STREET 2: STE 1105 CITY: PORTLAND STATE: OR ZIP: 97258 BUSINESS PHONE: 5032270554 MAIL ADDRESS: STREET 1: ONE SW COLUMBIA STREET 2: SUITE 1105 CITY: PORTLAND STATE: OR ZIP: 97258 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hudson Leslie CENTRAL INDEX KEY: 0001321265 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 08600104 BUSINESS ADDRESS: BUSINESS PHONE: 301-255-6840 MAIL ADDRESS: STREET 1: 1028 PRINCETON KINGSTON ROAD CITY: PRINCETON STATE: NJ ZIP: 08540 3 1 a3.xml 3 X0202 3 2008-02-08 0 0000873303 AVI BIOPHARMA INC AVII 0001321265 Hudson Leslie ONE SW COLUMBIA SUITE 1105 PORTLAND OR 97258 1 1 0 0 Chief Executive Officer No securities are benificially owned 0 D Exhibit List Exhibit 24. Power of Attorney By: Mark M. Webber, Attorney-in-fact For: Leslie Hudson 2008-02-11 EX-24 2 ex-24.htm EX-24

Exhibit 24

 

POWER OF ATTORNEY

 

Know all by these presents, that the undersigned hereby constitutes and appoints Mark M. Webber as the undersigned’s true and lawful attorney-in-fact to:

 

(1)                                  execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer and/or director of AVI BioPharma, Inc. (the “Company”), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder, and any other forms or reports the undersigned may be required to file in connection with the undersigned’s ownership, acquisition, or disposition of securities of the Company;

 

(2)                                  do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, or other form or report, and timely file such form or report with the United States Securities and Exchange Commission (the “SEC”) and any stock exchange or similar authority; and

 

(3)                                  take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

 

The undersigned hereby grants to such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

 

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 12 day of February, 2008.

 

 

 

/s/ Leslie Hudson

 

 

Signature

 

 

 

/s/ Dr. L. Hudson

 

 

Print Name

 

 -----END PRIVACY-ENHANCED MESSAGE-----